a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Exclusive Placement Agent for Jaguar Health, Inc. (JAGX) in its $10.8 Million Registered Direct Offering

Transaction Information Jaguar Health, Inc. (NASDAQ: JAGX) announced it has entered into a securities purchase...

Ladenburg Thalmann Acts as Co-Manager for SeaSpine Holdings Corporation (SPNE) in its $100.9 Million Follow-On Offering

Transaction Information SeaSpine Holdings Corporation (NASDAQ: SPNE) announced the pricing of its previously...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Immunome, Inc. (IMNM) in its $27.0 Million Private Placement

Transaction Information Immunome, Inc. (NASDAQ: IMNM) announced it has entered into a definitive securities purchase...

Ladenburg Thalmann Acts as Co-Manager for BrainsWay Ltd. (BWAY) in its $45.2 Million Follow-On Offering

Transaction Information BrainsWay Ltd. (NASDAQ: BWAY) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Salarius Pharmaceuticals, Inc. (SLRX) in its $23 Million Follow-On Offering

Transaction Information Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) announced the closing of its previously...

Ladenburg Thalmann Acts as Co-Manager for Cyclacel Pharmaceuticals, Inc. (CYCC) in its $14.5 Million Follow-On Offering

Transaction Information Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) announced the closing of its previously...

Ladenburg Thalmann Acts as Sole Book-Running Manager for CHF Solutions, Inc. (CHFS) in its $20.9 Million Follow-On Offering

Transaction Information CHF Solutions, Inc. (NASDAQ: CHFS) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Co-Placement Agent for 4D pharma plc (LBPS) in its $25 Million Private Placement

4D pharma plc (NASDAQ: LBPS), announced the completion of its private placement in connection with its merger with...

Ladenburg Thalmann Acts as Joint Book-Running Manager for Windtree Therapeutics, Inc. (WINT) in its $30.0 Million Follow-On Offering

Transaction Information Windtree Therapeutics, Inc. (NASDAQ: WINT) announced the closing of its previously announced...

  • 1
  • ...
  • 10
  • ...
  • 36